Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5'-PHOSPHATE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

31.4%
Female
68.6%
Male

Age Information

The average age of patients reporting adverse events with RIBOFLAVIN 5'-PHOSPHATE is 31.1 years.

Geographic Distribution

The majority of adverse event reports for RIBOFLAVIN 5'-PHOSPHATE originate from US.

Report Summary & Outcomes

249
Total Reports
249
As Primary/Secondary Suspect
0
Deaths Reported
3
Hospitalizations
3
Disabilities

Reporting Timeline

First adverse event report: 2015. Most recent report: 20210423. View full timeline →

More About RIBOFLAVIN 5'-PHOSPHATE

RIBOFLAVIN 5'-PHOSPHATE Full Profile Reports by Year Drug Interactions